Bloomberg
😐 Neutral
GLP-1 Opportunity to Lift Domestic Business at Indian Pharma Firms
A new and growing market for weight-loss drugs in India is expected to be a bright spot for pharmaceutical firms like Cipla Ltd. and Dr Reddy’s Laboratories Ltd., while they face headwinds in the US market.
Related Articles You May Like
Related News
Comments (0)
Leave a Comment
No comments yet. Be the first to comment!